ONCOPARSE
Who is ONCOPARSE?
Oncoparse is striving to revolutionize the early detection and treatment monitoring of Pancreatic Cancer by developing a cutting-edge bioinformatics pipeline. This pipeline is set to dramatically increase the precision and efficacy of variant calling from non-invasive liquid biopsies.
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Address:
MELBOURNE, 3000, AU
Employees by Department
- The Rest (2)
- Total (2)
Key Decision Makers
Omar Dabash
Chief Scientific Officer & Co-founder
Alex Krause
Research Scientist
Employees by Seniority
C-level
1employees
Senior
0employees
Non-managers
1employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of ONCOPARSE?
- Where is ONCOPARSE's headquarter?
- What ONCOPARSE's spending power?
- Does ONCOPARSE have a presence in the domain it operates in?